FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis and with the F508del CFTR mutation
1 finding from 1 review
Adverse events · adults and children with cystic fibrosis and with the F508del CFTR mutation
1 finding from 1 review
Time to first pulmonary exacerbation · adults and children with cystic fibrosis and with the F508del CFTR mutation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Survival · adults and children with cystic fibrosis and with at least one G551D CFTR mutation
1 finding from 1 review
QoL · adults and children with cystic fibrosis and with at least one G551D CFTR mutation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Weight loss (change in kg weight) · overweight or obese adults
1 finding from 1 review
Health‐related quality of life · overweight or obese adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Any adverse event (N) · overweight or obese adults
Summary of findings: fluoxetine showed no clear difference in any adverse event (N) compared with placebo (low certainty).
1 finding from 1 review
Anthropometric measurements other than weight loss in kg (BMI reduction measured inkg/m²) · overweight or obese adults
1 finding from 1 review
Morbidity: depression (N) · overweight or obese adults
It is very uncertain whether summary of findings: fluoxetine changes morbidity: depression (N) compared with placebo (very low certainty).
1 finding from 1 review
All‐cause mortality · overweight or obese adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Socioeconomic effects · overweight or obese adults
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of sleep · people with CKD
It is very uncertain whether summary of findings: relaxation changes sleep quality PSQI (median compared with control (very low certainty).
1 finding from 1 review
Sleep onset latency ‐ not reported · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HRQoL: CFQ, Medical Outcomes Study‐36 Item Short‐Form Health Survey, SF‐36 · people with CKD
Summary of findings: relaxation showed no clear difference in quality of life Quality of Life Index ‐ dialysis version and Medical… compared with control (low certainty).
1 finding from 1 review
Depressive symptoms · people with CKD
It is very uncertain whether summary of findings: relaxation changes depression Center for Epidemiologic Studies Depression Scale and The… compared with control (very low certainty).
1 finding from 1 review
Anxiety · people with CKD
It is very uncertain whether summary of findings: relaxation changes anxiety Beck Anxiety Inventory and Spielberger State‐Trait Anxiety… compared with control (very low certainty).
1 finding from 1 review
Fatigue · people with CKD
It is very uncertain whether summary of findings: relaxation changes fatigue PROMIS‐Fatigue Short Form 1.0 and Rhoten and Piper fatigue… compared with control (very low certainty).
1 finding from 1 review
Hospitalisation (median · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Seizure freedom · Children with acute tonic‐clonic seizures
Summary of findings ‐ Lorazepam showed no clear difference in seizure cessation compared with diazepam (low certainty).
1 finding from 1 review